(Q46137549)

English

Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.

scientific article published on 29 January 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

title

Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

main subject

mucoepidermoid carcinoma

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

author name string

Iain D O'Neill

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/19185385

publication date

29 January 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

volume

64

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

page(s)

129-130

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Identifiers

DOI

10.1016/J.LUNGCAN.2009.01.003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

PubMed publication ID

19185385

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19185385

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19185385%20AND%20SRC:MED&resulttype=core&format=json

(Q46137549)

Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)